546
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Sample size for comparing negative binomial rates in noninferiority and equivalence trials with unequal follow-up times

Pages 475-491 | Received 04 Oct 2016, Accepted 16 Apr 2017, Published online: 31 Aug 2017

References

  • Aban, I. B., Cutter, G. R., Mavinga, N. (2009). Inferences and power analysis concerning two negative binomial distributions with an application to MRI lesion counts data. Computational Statistics & Data Analysis 53: 820–833.
  • Alten, R., Cronstein, B. N. (2015). Clinical trial development for biosimilars. Seminars in Arthritis and Rheumatism 44: S2–S8.
  • Chow, S. C., Wang, H. (2001). On sample size calculation in bioequivalence trials. Journal of Pharmacokinetics and Pharmacodynamics 28(2): 155–169.
  • Chow, S.-C., Wang, H., Shao, J. (2008). Sample Size Calculations in Clinical Research. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC.
  • Cook, R. J. (1995). The design and analysis of randomized trials with recurrent events. Statistics in Medicine 14: 2081–2098.
  • Cook, R. J., Lee, K.-A., Li, H. (2007). Non-inferiority trial design for recurrent events. Statistics in Medicine 26: 4563–4577.
  • EMA-CHMP. (2005). Guideline on the Choice of the Noninferiority Margin. London.
  • Friede, T., Schmidli, H. (2010). Blinded sample size reestimation with count data: Methods and applications in multiple sclerosis. Statistics in Medicine 29: 1145–1156.
  • Glynn, R. J., Buring, J. E. (1996). Ways of measuring rates of recurrent events. BMJ 312: 364–366.
  • Hahn, H. (2012). Understanding noninferiority trials. Korean Journal of Pediatrics 55: 403–407.
  • Hung, H. M. J., Wang, S. J., O’Neill, R. T. (2007). Issues with statistical risks for testing methods in noninferiority trial without a placebo arm. Journal of Biopharmaceutical Statistics 17: 201–213.
  • Hung, H. M. J., Wang, S. J., Tsong, Y., Lawrence, J., O’Neill, R. T. (2003). Some fundamental issues with non-inferiority testing in active controlled clinical trials. Statistics in Medicine 22: 213–225.
  • Lachin, J. M., Foulkes, M. A. (1986). Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics 42: 507–519.
  • Lawless, J. F. (1987). Negative binomial and mixed Poisson regression. The Canadian Journal of Statistics 15: 209–225.
  • Liao, J. J. (2015). A constrained non-inferiority approach for assessing clinical efficacy to establish biosimilarity. International Journal of Clinical Biostatistics and Biometrics 1: 1–7.
  • Saha, K., Paul, S. (2005). Bias-corrected maximum likelihood estimator of the negative binomial dispersion parameter. Biometrics 61: 179–185.
  • Tang, Y. (2015). Sample size estimation for negative binomial regression comparing rates of recurrent events with unequal follow-up time. Journal of Biopharmaceutical Statistics 25: 1100–1113.
  • Tang, Y. (2017). Negative binomial regression: Sample size with unequal follow-up times. In: Encyclopedia of Biopharmaceutical Statistics, 3rd ed. Edited by Shein-Chung Chow. Taylor and Francis: New York. doi: 10.1081/E-EBS3-140000049.
  • US-FDA. (2010). Guidance for Industry Non-Inferiority Clinical Trials.
  • US-FDA. (2012). Guidance for industry: Scientific considerations in demonstrating biosimilarity to a reference product.
  • Wang, Y., Meyerson, L., Tang, Y., Qian, N. (2009). Statistical methods for the analysis of relapse data in MS clinical trials. Journal of the Neurological Sciences 285: 206–211.
  • Zhu, H. (2017). Sample size calculation for comparing two Poisson or negative binomial rates in non-inferiority or equivalence trials. Statistics in Biopharmaceutical Research 9: 107–115.
  • Zhu, H., Lakkis, H. (2014). Sample size calculation for comparing two negative binomial rates. Statistics in medicine 33: 376–387.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.